IMARC Group’s report titled “Atherectomy Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032”, offers a comprehensive analysis of the industry, which comprises insights on the global atherectomy devices market growth. The global market size reached US$ 978.0 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,476.0 Million by 2032, exhibiting a growth rate (CAGR) of 4.5% during 2024-2032.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/atherectomy-devices-market/requestsample

Factors Affecting the Growth of the Atherectomy Devices Industry:

• Increasing Prevalence of Peripheral Artery Disease (PAD):

The growing demand for atherectomy devices on account of the rising prevalence of peripheral artery diseases (PAD) among the masses across the globe is offering a positive market outlook. PAD is a common circulatory problem where narrowed arteries reduce blood flow to limbs, often due to atherosclerosis. People are facing these diseases due to sedentary lifestyles, increasing rates of diabetes and obesity, and smoking. This growing prevalence necessitates more effective and targeted treatments, thereby increasing the demand for atherectomy devices that can efficiently remove arterial plaque and restore blood flow.

• Aging Population:

The escalating demand for atherectomy devices due to the rising geriatric population is supporting the market growth. The aging population is particularly vulnerable to cardiovascular diseases, including those affecting peripheral arteries. As people age, their vascular system naturally degenerates, leading to an increased incidence of arterial diseases. This demographic shift towards an older population increases the demand for cardiovascular procedures, including atherectomy, to manage and treat age-related arterial conditions effectively. Atherectomy offers a safer and less invasive option for this age group, who may not be ideal candidates for more invasive procedures.

• Technological Advancements:

Innovations assist in enhancing the efficacy and safety of these devices, such as features that ensure more precise plaque removal, minimize risks during procedures, and adapt to various types of arterial lesions. Advancements like directional atherectomy allow selective cutting of plaque, and orbital and rotational devices benefit in adjusting to artery size and plaque consistency. These are beneficial in improving patient outcomes and expanding the applicability of atherectomy in vascular interventions. Furthermore, devices equipped with ultrasound or optical coherence tomography (OCT) allow real time visualization of the artery and plaque during the procedure. This technology provides surgeons with a detailed view of the treatment area, enhancing accuracy and reducing the risk of complications.

Leading Companies Operating in the Atherectomy Devices Industry:

• Abbott Laboratories, Avinger
• Braun Melsungen AG
• Biomerics, Biotronik
• Boston Scientific Corporation
• R. Bard (Becton, Dickinson and Company)
• Cardinal Health
• Koninklijke Philips N.V.
• Medtronic
• Minnetronix Inc.
• Straub Medical AG (Becton, Dickinson and Company)
• Terumo Corporation

Atherectomy Devices Market Report Segmentation:

By Product:

• Directional Atherectomy Devices
• Orbital Atherectomy Devices
• Photo-Ablative Atherectomy Devices
• Rotational Atherectomy Devices
• Support Devices

Directional atherectomy devices represent the largest segment as they allow for the targeted removal of plaque from the arterial walls.   

By Application:

• Peripheral Vascular
• Cardiovascular
• Neurovascular

Peripheral vascular holds the biggest market share due to the high prevalence of peripheral artery disease.   

By End User:

• Hospitals
• Ambulatory Surgery Centers
• Research Laboratories and Academic Institutes

Hospitals exhibit a clear dominance in the market on account of their ability to provide comprehensive care facilities.  

Regional Insights:

• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

North America enjoys a leading position in the atherectomy devices market, which can be driven by the presence of advanced healthcare infrastructure.   

Global Atherectomy Devices Market Trends:

Rising preferences for minimally invasive (MI) surgical approaches over traditional surgeries due to their benefits, including reduced recovery times, lesser pain, and lower risk of infection, are propelling the growth of the market. Atherectomy is a MI procedure that helps in removing plaque from arteries, aligning well with this trend. Patients and healthcare providers are adopting these procedures because they generally allow for quicker returns to normal activities and fewer hospital stays, which is also cost-effective for healthcare systems.  

In line with this, expanding healthcare infrastructure, along with increasing access to advanced medical technologies, is contributing to the market growth.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact Us:

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145